Theme hub · 276 companies
Oncology stocks
Daily analysis · Oct 27, 2026
Biodexa Pharmaceuticals Plc (BDRX) posted a 771.7% one-day move, while 118 companies fell and 64 rose in the latest session.
- AstraZeneca PLC (A1ZN34.SA): +16.1% one day move, mega cap
- Summit Therapeutics Inc. (SMMT): −6.3% one day move, large cap
- Xencor, Inc. (XNCR): +15.9% one day move, mid cap
Generated from today's data · Not investment advice
Heavily traded in Oncology
Turnover over $10M/day71 of about 280 companies in this theme turn over more than $10M in a typical session. Largest market value first. Data as of Oct 27, 2026.
| Company | Turnover | 1Y return | Next report |
|---|---|---|---|
| MRKMerck & Co., Inc. | $1.24B | +62.34% | Reports Oct 29, 2026 |
| BMYBristol-Myers Squibb Company | $604.97M | +45.15% | Reports Oct 29, 2026 |
| 4519.TChugai Pharmaceutical Co., Ltd. | $17.60B | +1.90% | Reports Oct 27, 2026 |
| ONCBeOne Medicines AG | $130.34M | +17.58% | Reports Nov 5, 2026 |
| RVMDRevolution Medicines, Inc. | $334.27M | +217.12% | Reports Nov 4, 2026 |
| 4568.TDaiichi Sankyo Company, Limited | $16.97B | −28.59% | Reports Oct 30, 2026 |
| GMABGenmab A/S | $123.02M | +53.93% | Reports Nov 5, 2026 |
| INCYIncyte Corporation | $160.31M | +21.73% | Reports Oct 29, 2026 |
MRK+62.34%$1.24BReports Oct 29, 2026Pre-earnings analysisBMY+45.15%$604.97MReports Oct 29, 2026Pre-earnings analysis4519.T+1.90%$17.60BReports Oct 27, 2026Pre-earnings analysisONC+17.58%$130.34MReports Nov 5, 2026Pre-earnings analysisRVMD+217.12%$334.27MReports Nov 4, 2026Pre-earnings analysis4568.T−28.59%$16.97BReports Oct 30, 2026Pre-earnings analysisGMAB+53.93%$123.02MReports Nov 5, 2026Pre-earnings analysisINCY+21.73%$160.31MReports Oct 29, 2026Pre-earnings analysisTurnover over $10M/day
Turnover is the median value traded in one session, measured over the past 50 sessions. It describes trading activity in a stock and nothing about the company behind it.
Table
276 companies, largest market value first.
Data as of Oct 27, 2026 · updates nightly, Mon–Sat
| Ticker | Company | Market cap (USD) | Size | 1Y return |
|---|---|---|---|---|
| MRK | Merck & Co., Inc. | $346.91B | Mega cap | +62.34% |
| BMY | Bristol-Myers Squibb Company | $125.85B | Large cap | +45.15% |
| 4519.T | Chugai Pharmaceutical Co., Ltd. | $72.04B | Large cap | +1.90% |
| ONC | BeOne Medicines AG | $42.19B | Large cap | +17.58% |
| RVMD | Revolution Medicines, Inc. | $40.08B | Large cap | +217.12% |
| 4568.T | Daiichi Sankyo Company, Limited | $32.62B | Large cap | −28.59% |
| GMAB | Genmab A/S | $27.48B | Large cap | +53.93% |
| INCY | Incyte Corporation | $22.97B | Large cap | +21.73% |
| EXEL | Exelixis, Inc. | $16.13B | Large cap | +62.82% |
| SMMT | Summit Therapeutics Inc. | $11.57B | Large cap | −25.49% |
| NUVL | Nuvalent Inc | $9.79B | Mid cap | +26.87% |
| 4528.T | Ono Pharmaceutical Co., Ltd. | $7.47B | Mid cap | +36.24% |
| LNTH | Lantheus Holdings, Inc. | $6.52B | Mid cap | +71.89% |
| CGON | CG Oncology, Inc. | $5.46B | Mid cap | +38.99% |
| COGT | Cogent Biosciences, Inc. | $5.36B | Mid cap | +90.80% |
| ERAS | Erasca, Inc. | $5.24B | Mid cap | +527.20% |
| 000100.KS | Yuhan Corporation | $4.61B | Mid cap | −28.74% |
| RLAY | Relay Therapeutics, Inc. | $3.97B | Mid cap | +145.53% |
| 000105.KS | Yuhan Corporation | $3.90B | Mid cap | −33.07% |
| TNGX | Tango Therapeutics, Inc. | $3.74B | Mid cap | +185.65% |
| CELC | Celcuity Inc. | $3.22B | Mid cap | −15.11% |
| IDYA | IDEAYA Biosciences, Inc. | $3.17B | Mid cap | +1.58% |
| TLX.AX | Telix Pharmaceuticals Limited | $3.06B | Mid cap | −22.92% |
| TLX | Telix Pharmaceuticals Limited | $3.05B | Mid cap | −17.90% |
| ELVN | Enliven Therapeutics, Inc. | $3.04B | Mid cap | +93.88% |
| NRIX | Nurix Therapeutics, Inc. | $2.77B | Mid cap | +113.27% |
| ZLAB | Zai Lab Limited | $2.73B | Mid cap | −7.59% |
| HCM | HUTCHMED (China) Limited | $2.48B | Mid cap | −3.97% |
| SLS | SELLAS Life Sciences Group, Inc. | $2.33B | Mid cap | +484.54% |
| RCUS | Arcus Biosciences, Inc. | $2.26B | Mid cap | −4.52% |
| XNCR | Xencor, Inc. | $2.17B | Mid cap | +104.48% |
| IMNM | Immunome, Inc. | $2.11B | Mid cap | +7.77% |
| ZYME | Zymeworks Inc. | $2.04B | Mid cap | +53.60% |
| VIR | Vir Biotechnology, Inc. | $1.87B | Small cap | +78.35% |
| NVCR | NovoCure Limited | $1.68B | Small cap | +6.04% |
| URGN | UroGen Pharma Ltd. | $1.66B | Small cap | +63.26% |
| IMCR | Immunocore Holdings plc | $1.61B | Small cap | −6.52% |
| NBTX | Nanobiotix S.A. | $1.61B | Small cap | +109.08% |
| NUVB | Nuvation Bio Inc. | $1.58B | Small cap | −10.52% |
| AAPG | Ascentage Pharma Group Internat | $1.44B | Small cap | −55.30% |
| DMRA | Damora Therapeutics, Inc. | $1.31B | Small cap | +189.45% |
| INBX | Inhibrx Biosciences, Inc. | $1.30B | Small cap | +50.57% |
| DRTS | Alpha Tau Medical Ltd. | $1.19B | Small cap | +209.86% |
| 4588.T | Oncolys BioPharma Inc. | $1.18B | Small cap | +723.61% |
| REPL | Replimune Group, Inc. | $1.17B | Small cap | +33.65% |
| SNDX | Syndax Pharmaceuticals, Inc. | $1.17B | Small cap | +0.84% |
| 2160.T | GNI Group Ltd. | $1.13B | Small cap | +7.82% |
| BCAX | Bicara Therapeutics Inc. | $1.12B | Small cap | −0.65% |
| IMTX | Immatics N.V. | $1.11B | Small cap | −32.42% |
| JANX | Janux Therapeutics, Inc. | $1.02B | Small cap | −38.98% |
| CGEM | Cullinan Therapeutics, Inc. | $935.72M | Small cap | +80.40% |
| ORIC | ORIC Pharmaceuticals, Inc. | $928.21M | Small cap | −33.17% |
| VSTM | Verastem, Inc. | $905.63M | Small cap | +14.68% |
| GLUE | Monte Rosa Therapeutics, Inc. | $894.08M | Small cap | −14.94% |
| RIGL | Rigel Pharmaceuticals, Inc. | $890.51M | Small cap | +68.73% |
| CRVS | Corvus Pharmaceuticals, Inc. | $879.06M | Small cap | +32.95% |
| AKTS | Aktis Oncology, Inc. | $874.89M | Small cap | −29.78% |
| 4587.T | PeptiDream Inc. | $865.74M | Small cap | −35.53% |
| KURA | Kura Oncology, Inc. | $855.80M | Small cap | −12.86% |
| AVBP | ArriVent BioPharma, Inc. | $757.37M | Small cap | −21.19% |
| GERN | Geron Corporation | $719.57M | Small cap | −10.16% |
| ANL | Adlai Nortye Group Ltd. | $681.33M | Small cap | +600.66% |
| SGMT | Sagimet Biosciences Inc. | $677.89M | Small cap | +11.16% |
| AURA | Aura Biosciences, Inc. | $653.34M | Small cap | +1.31% |
| NVCT | Nuvectis Pharma, Inc. | $603.59M | Small cap | +182.29% |
| CADL | Candel Therapeutics, Inc. | $596.08M | Small cap | +44.26% |
| OLMA | Olema Pharmaceuticals, Inc. | $579.23M | Small cap | −24.69% |
| PBYI | Puma Biotechnology, Inc. | $560.08M | Small cap | +105.88% |
| DCTH | Delcath Systems, Inc. | $503.48M | Small cap | +45.25% |
| CTMX | CytomX Therapeutics, Inc. | $484.83M | Small cap | −33.78% |
| ARVN | Arvinas, Inc. | $477.97M | Small cap | −24.25% |
| MNPR | Monopar Therapeutics Inc. | $474.21M | Small cap | −13.17% |
| CBIO | Crescent Biopharma, Inc. | $473.99M | Small cap | −1.85% |
| INDP | Indaptus Therapeutics, Inc. | $445.03M | Small cap | −5.92% |
| CU6.AX | Clarity Pharmaceuticals Ltd | $412.47M | Small cap | −65.15% |
| CCCC | C4 Therapeutics, Inc. | $366.61M | Small cap | +12.45% |
| FENC | Fennec Pharmaceuticals Inc. | $353.48M | Small cap | +15.08% |
| RLMD | Relmada Therapeutics, Inc. | $344.54M | Small cap | +38.63% |
| GALT | Galectin Therapeutics Inc. | $321.71M | Small cap | −37.45% |
| EIKN | Eikon Therapeutics, Inc. | $300.07M | Small cap | −63.07% |
| PRLD | Prelude Therapeutics Incorporated | $289.11M | Small cap | +116.37% |
| AGEN | Agenus Inc. | $278.20M | Small cap | +48.43% |
| BCYC | Bicycle Therapeutics plc | $254.81M | Small cap | −55.05% |
| GLSI | Greenwich LifeSciences, Inc. | $251.36M | Small cap | +74.92% |
| IMRX | Immuneering Corporation | $240.03M | Small cap | −41.11% |
| RAC.AX | Racura Oncology Ltd | $226.40M | Small cap | −50.90% |
| BBOT | BridgeBio Oncology Therapeutics, Inc. | $211.66M | Small cap | −76.66% |
| ZNTL | Zentalis Pharmaceuticals, Inc. | $203.11M | Small cap | +20.35% |
| PYXS | Pyxis Oncology, Inc. | $201.88M | Small cap | −50.15% |
| ADCT | ADC Therapeutics SA | $192.78M | Small cap | −64.80% |
| WHWK | Whitehawk Therapeutics, Inc. | $179.01M | Small cap | +29.75% |
| CGEN | Compugen Ltd. | $177.61M | Small cap | +9.65% |
| ADAG | Adagene Inc. | $167.19M | Small cap | +34.96% |
| IPHA | Innate Pharma S.A. | $163.08M | Small cap | −38.66% |
| SPL.AX | Starpharma Holdings Limited | $156.84M | Small cap | +39.71% |
| ALXO | ALX Oncology Holdings Inc. | $156.25M | Small cap | −33.53% |
| CHRS | Coherus Oncology, Inc. | $156.05M | Small cap | −36.88% |
| STRO | Sutro Biopharma, Inc. | $154.70M | Small cap | −23.41% |
| ASRT | Assertio Holdings Inc | $151.86M | Small cap | +93.42% |
| NBP | NovaBridge Biosciences | $140.94M | Small cap | −74.15% |
| MGNX | MacroGenics, Inc. | $139.50M | Small cap | +14.66% |
| TARA | Protara Therapeutics, Inc. | $138.87M | Small cap | −54.10% |
| CATX | Perspective Therapeutics, Inc. | $138.12M | Small cap | −60.97% |
| MOLN | Molecular Partners AG | $137.52M | Small cap | 0.00% |
| MENS | Jyong Biotech Ltd. | $134.57M | Small cap | −96.46% |
| CMPX | Compass Therapeutics, Inc. | $134.56M | Small cap | −81.82% |
| CUE | Cue Biopharma, Inc. | $134.03M | Small cap | −20.13% |
| HURA | TuHURA Biosciences, Inc. | $130.00M | Small cap | −11.30% |
| FHTX | Foghorn Therapeutics Inc. | $121.74M | Small cap | −50.24% |
| 0RDB.L | Oryzon Genomics S.A. | $121.50M | Small cap | −21.19% |
| KZIA | Kazia Therapeutics Limited | $121.44M | Small cap | +7.81% |
| ANIX | Anixa Biosciences, Inc. | $101.86M | Small cap | −32.33% |
| OKUR | OnKure Therapeutics, Inc. | $99.98M | Micro cap | −30.67% |
| 4579.T | RaQualia Pharma Inc. | $99.95M | Micro cap | +12.05% |
| AMAN | Amanat Acquisition Corp | $98.69M | Micro cap | +1.90% |
| BDTX | Black Diamond Therapeutics, Inc. | $97.10M | Micro cap | −57.22% |
| PMVP | PMV Pharmaceuticals, Inc. | $95.90M | Micro cap | −28.48% |
| RVU.WA | Ryvu Therapeutics S.A. | $95.00M | Micro cap | −31.01% |
| 4575.T | CanBas Co., Ltd. | $92.03M | Micro cap | −14.91% |
| 4888.T | Stella Pharma Corporation | $90.98M | Micro cap | +21.47% |
| GNLX | Genelux Corporation | $86.42M | Micro cap | −73.84% |
| 4889.T | Renascience Inc. | $84.73M | Micro cap | −48.42% |
| NTHI | NeOnc Technologies Holdings, Inc. | $81.23M | Micro cap | −65.78% |
| JATT | JATT II Acquisition Corp. | $80.26M | Micro cap | −2.00% |
| PDSB | PDS Biotechnology Corporation | $77.19M | Micro cap | +14.03% |
| CRBP | Corbus Pharmaceuticals Holdings, Inc. | $77.17M | Micro cap | −76.54% |
| ACRV | Acrivon Therapeutics, Inc. | $73.71M | Micro cap | −17.70% |
| MAIA | MAIA Biotechnology, Inc. | $68.53M | Micro cap | −26.00% |
| CTOR | Citius Oncology, Inc. | $63.00M | Micro cap | −65.37% |
| CRDF | Cardiff Oncology, Inc. | $62.57M | Micro cap | −64.88% |
| ONCY | Oncolytics Biotech Inc. | $62.05M | Micro cap | −60.89% |
| VRCA | Verrica Pharmaceuticals Inc. | $58.75M | Micro cap | −9.04% |
| RNXT | RenovoRx, Inc. | $58.22M | Micro cap | +13.91% |
| APLM | Apollomics, Inc. | $58.01M | Micro cap | −13.48% |
| HRTX | Heron Therapeutics, Inc. | $57.09M | Micro cap | −74.52% |
| OSTX | OS Therapies Incorporated | $56.63M | Micro cap | −38.27% |
| XBIT | XBiotech Inc. | $56.40M | Micro cap | −28.02% |
| BOLD | Boundless Bio, Inc. | $55.69M | Micro cap | +61.74% |
| SVE.WA | Synthaverse S.A. | $54.73M | Micro cap | −33.49% |
| PLRX | Pliant Therapeutics, Inc. | $53.48M | Micro cap | −52.79% |
| ELTX | Elicio Therapeutics, Inc. | $51.47M | Micro cap | −82.47% |
| XLO | Xilio Therapeutics, Inc. | $48.10M | Micro cap | −37.17% |
| HOWL | Werewolf Therapeutics, Inc. | $47.66M | Micro cap | −41.98% |
| 4583.T | Chiome Bioscience Inc. | $47.37M | Micro cap | −29.69% |
| 4597.T | Solasia Pharma K.K. | $46.78M | Micro cap | −22.86% |
| 4572.T | Carna Biosciences, Inc. | $46.72M | Micro cap | +60.55% |
| 4564.T | OncoTherapy Science, Inc. | $44.05M | Micro cap | −25.00% |
| ATNM | Actinium Pharmaceuticals, Inc. | $44.02M | Micro cap | −8.50% |
| MOC.WA | Molecure S.A. | $41.43M | Micro cap | −18.95% |
| PTX.AX | Prescient Therapeutics Limited | $40.95M | Micro cap | −3.77% |
| TIL | Instil Bio, Inc. | $37.78M | Micro cap | −71.97% |
| 4594.T | BrightPath Biotherapeutics Co., Ltd. | $35.26M | Micro cap | −40.00% |
| EVAX | Evaxion A/S | $33.92M | Micro cap | −49.76% |
| CANTA.ST | Cantargia AB (publ) | $33.17M | Micro cap | −46.05% |
| IBO | Impact BioMedical Inc. | $31.87M | Micro cap | +539.79% |
| 206A.T | PRISM BioLab Co.,LTD | $31.44M | Micro cap | −20.00% |
| RNAZ | TransCode Therapeutics, Inc. | $29.97M | Micro cap | −87.02% |
| ATX.AX | Amplia Therapeutics Limited | $28.10M | Micro cap | −40.00% |
| ABVC | ABVC BioPharma, Inc. | $28.03M | Micro cap | −63.67% |
| CVM | CEL-SCI Corporation | $27.97M | Micro cap | −82.39% |
| NNG.WA | NanoGroup S.A. | $26.65M | Micro cap | −5.60% |
| SNT.AX | Syntara Limited | $26.20M | Micro cap | −38.71% |
| ATOS | Atossa Therapeutics, Inc. | $24.45M | Micro cap | −82.62% |
| NXTC | NextCure, Inc. | $23.92M | Micro cap | −43.64% |
| 4582.T | SymBio Pharmaceuticals Limited | $23.91M | Micro cap | −60.98% |
| 190A.T | Chordia Therapeutics Inc. | $23.87M | Micro cap | −56.52% |
| IMM.AX | Immutep Limited | $23.83M | Micro cap | −92.20% |
| IMMP | Immutep Limited | $23.58M | Micro cap | +51.96% |
| BKHA | Black Hawk Acquisition Corporation | $22.43M | Micro cap | −52.88% |
| CNTX | Context Therapeutics Inc. | $22.04M | Micro cap | −80.50% |
| ITOC | iTonic Holdings Ltd. | $20.48M | Micro cap | +308.06% |
| MAAT.PA | MaaT Pharma SA | $19.63M | Micro cap | −76.80% |
| BYSI | BeyondSpring Inc. | $18.92M | Micro cap | −75.40% |
| KYNB | Kyntra Bio, Inc. | $18.22M | Micro cap | −59.53% |
| AKTX | Akari Therapeutics, Plc | $17.44M | Micro cap | −75.98% |
| CCM | Concord Medical Services Holdings Limited | $16.91M | Micro cap | −29.44% |
| 4882.T | Perseus Proteomics Inc. | $16.14M | Micro cap | −54.30% |
| BOLT | Bolt Biotherapeutics, Inc. | $15.53M | Micro cap | +5.61% |
| RAD.AX | Radiopharm Theranostics Limited | $15.36M | Micro cap | −80.00% |
| MRKR | Marker Therapeutics, Inc. | $15.11M | Micro cap | −12.00% |
| RADX | Radiopharm Theranostics Limited | $14.74M | Micro cap | −81.12% |
| ALLR | Allarity Therapeutics, Inc. | $14.56M | Micro cap | −31.71% |
| IMU.AX | Imugene Limited | $13.61M | Micro cap | −91.03% |
| BFRI | Biofrontera Inc. | $12.21M | Micro cap | −19.80% |
| LSTA | Lisata Therapeutics, Inc. | $11.45M | Micro cap | −62.14% |
| CLRB | Cellectar Biosciences, Inc. | $11.44M | Micro cap | −66.30% |
| CTXR | Citius Pharmaceuticals, Inc. | $11.07M | Micro cap | −72.18% |
| KPTI | Karyopharm Therapeutics Inc. | $10.93M | Micro cap | −92.49% |
| NOX.AX | Noxopharm Limited | $10.57M | Micro cap | −47.87% |
| GTBP | GT Biopharma, Inc. | $10.45M | Micro cap | +630.55% |
| INTS | Intensity Therapeutics, Inc. | $10.45M | Micro cap | −47.54% |
| BLRX | BioLineRx Ltd. | $10.01M | Micro cap | −46.54% |
| PHIO | Phio Pharmaceuticals Corp. | $9.90M | Micro cap | −60.68% |
| LTRN | Lantern Pharma Inc. | $9.32M | Micro cap | −84.60% |
| TOVX | Theriva Biologics, Inc. | $8.88M | Micro cap | −41.39% |
| TPST | Tempest Therapeutics, Inc. | $8.62M | Micro cap | −95.37% |
| BDRX | Biodexa Pharmaceuticals Plc | $8.13M | Micro cap | −90.09% |
| MBRX | Moleculin Biotech, Inc. | $7.22M | Micro cap | −42.86% |
| CURX | Curanex Pharmaceuticals Inc | $7.21M | Micro cap | +475.01% |
| IMNN | Imunon, Inc. | $6.90M | Micro cap | −73.94% |
| CNSP | CNS Pharmaceuticals, Inc. | $6.76M | Micro cap | −44.61% |
| OSRH | OSR Health, Inc. | $6.67M | Micro cap | −70.91% |
| PAB.AX | Patrys Limited | $6.64M | Micro cap | −40.00% |
| 4598.T | Delta-Fly Pharma, Inc. | $6.59M | Micro cap | −84.28% |
| AIM | AIM ImmunoTech Inc. | $6.53M | Micro cap | −93.55% |
| APRE | Aprea Therapeutics, Inc. | $5.65M | Micro cap | −66.49% |
| CANF | Can-Fite BioPharma Ltd. | $5.21M | Micro cap | −81.70% |
| PCSA | Processa Pharmaceuticals, Inc. | $5.02M | Micro cap | −76.91% |
| PER.AX | Percheron Therapeutics Limited | $4.87M | Micro cap | −56.25% |
| XBIO | Xenetic Biosciences, Inc. | $4.33M | Micro cap | −50.67% |
| NCNA | NuCana plc | $4.33M | Micro cap | −75.93% |
| NFX.L | Nuformix plc | $4.32M | Micro cap | −57.55% |
| LIMN | Liminatus Pharma, Inc. | $4.24M | Micro cap | +146.88% |
| RDHL | RedHill Biopharma Ltd. | $3.70M | Micro cap | −73.51% |
| MDCX | Medicus Pharma Ltd. | $3.60M | Micro cap | +5.02% |
| PPCB | Propanc Biopharma, Inc. | $2.89M | Micro cap | −93.81% |
| IVX.AX | Invion Limited | $2.87M | Micro cap | −61.05% |
| SLXN | Silexion Therapeutics Corp | $2.73M | Micro cap | −94.97% |
| APVO | Aptevo Therapeutics Inc. | $2.72M | Micro cap | −94.44% |
| HCWB | HCW Biologics Inc. | $2.46M | Micro cap | −71.43% |
| VAL.L | ValiRx plc | $2.36M | Micro cap | −75.24% |
| CLDI | Calidi Biotherapeutics, Inc. | $2.35M | Micro cap | −58.71% |
| BCAB | BioAtla, Inc. | $2.27M | Micro cap | −96.30% |
| DCOY | Decoy Therapeutics Inc. | $2.20M | Micro cap | −98.00% |
| GOVX | GeoVax Labs, Inc. | $1.96M | Micro cap | −98.64% |
| KAPA | Kairos Pharma, Ltd. | $1.81M | Micro cap | −53.38% |
| PPBT | Purple Biotech Ltd | $1.64M | Micro cap | −83.03% |
| NX1.AX | Nexalis Therapeutics Limited | $1.60M | Micro cap | −59.09% |
| LNAI | Lunai Bioworks Inc. | $1.25M | Micro cap | −96.73% |
| ARTL | Artelo Biosciences, Inc. | $1.21M | Micro cap | −78.24% |
| PTP.DE | Pentixapharm Holding AG | $1.04M | Micro cap | +2.51% |
| CRIS | Curis, Inc. | $914.98K | Micro cap | −75.81% |
| NXTS | Nexentis Technologies Inc. | $817.21K | Micro cap | −97.84% |
| 0HL9.L | Affimed N.V. | — | — | 0.00% |
| 0LC7.L | Syros Pharmaceuticals, Inc. | — | — | −50.00% |
| A1ZN34.SA | AstraZeneca PLC | — | Mega cap | +3.81% |
| ABERA.ST | Abera Bioscience AB | — | Small cap | +10.55% |
| ACTI.ST | Active Biotech AB (publ) | — | Small cap | −57.90% |
| ALOPM.PA | Oncodesign Precision Medicine Société anonyme | — | — | −31.11% |
| ALTME.PA | TME Pharma N.V. | — | — | +15.75% |
| ALVIO.PA | Valerio Therapeutics Société anonyme | — | Small cap | +586.89% |
| ATORX.ST | Alligator Bioscience AB (publ) | — | — | −99.62% |
| AVCT.L | Avacta Group Plc | — | Small cap | +4.62% |
| AZN.L | AstraZeneca PLC | — | Large cap | −1.30% |
| B8FK.DE | Biofrontera AG | — | — | +12.36% |
| BCT.TO | BriaCell Therapeutics Corp. | — | — | −74.12% |
| BINV.ST | BioInvent International AB (publ) | — | Small cap | −20.00% |
| CHOSA.ST | Chosa Oncology AB | — | — | −59.68% |
| COIL.L | Coiled Therapeutics plc | — | — | −67.14% |
| CRTX.L | CRISM Therapeutics Corporation | — | — | −18.18% |
| CTX.WA | Captor Therapeutics Spolka Akcyjna | — | Small cap | +33.65% |
| CURAS.CO | Curasight A/S | — | — | −63.08% |
| DBP-B.ST | Double Bond Pharmaceutical International AB (publ) | — | — | +7.18% |
| DEX.ST | Dextech Medical AB | — | Small cap | +38.89% |
| E2XE34.SA | Exelixis, Inc. | — | Large cap | +29.33% |
| EUZ.DE | Eckert & Ziegler SE | — | Small cap | −25.92% |
| GUD.TO | Knight Therapeutics Inc. | — | Small cap | +98.46% |
| GXE.DE | Lakefront Biotherapeutics NV | — | Small cap | −40.32% |
| HBP.TO | Helix BioPharma Corp. | — | Small cap | −53.52% |
| HCM.L | HUTCHMED (China) Limited | — | Small cap | −2.25% |
| HPHA.DE | Heidelberg Pharma AG | — | Small cap | −25.17% |
| IPH.PA | Innate Pharma S.A. | — | Small cap | −29.43% |
| IPN.PA | Ipsen S.A. | — | Large cap | +30.52% |
| J8J.F | TransThera Sciences (Nanjing), Inc. | — | Small cap | −91.52% |
| MDNA.TO | Medicenna Therapeutics Corp. | — | — | −72.19% |
| MOLN.SW | Molecular Partners AG | — | — | +11.27% |
| NANO.PA | Nanobiotix S.A. | — | Small cap | −13.93% |
| OSE.PA | OSE Immunotherapeutics SA | — | Small cap | −63.95% |
| PHIL.MI | Philogen S.p.A. | — | Small cap | −8.66% |
| POLB.L | Poolbeg Pharma PLC | — | — | +89.39% |
| PRTC.L | PureTech Health plc | — | Small cap | −14.39% |
| SAR.L | Sareum Holdings plc | — | — | −98.31% |
| SCLP.L | Scancell Holdings plc | — | Small cap | −2.62% |
| T9G.DE | Vidac Pharma Holding Plc | — | — | −38.97% |
| TNG.PA | Transgene SA | — | Small cap | −49.41% |
| TRAW | Traws Pharma, Inc. | — | — | −86.88% |
Covers ~23,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Price and the 52-week distance are in the currency the stock trades in; only market values are converted.
We cover 276 companies grouped under the Oncology theme. The median market value in the group is $95.90M. Among the 188 with a price from the latest session, the median move over the past trading day is −1.09%. 22% of the 266 with a 200-day average trade above it. Price change over the past year runs from −81.4% to +76.6% across the middle 80 percent of the group, with a median of −26.0%.
Other lists in this group
OncologyAdvanced packagingAerospaceAgriculture and agribusinessAI applicationsAI chipsAI datacenter infrastructureAirlinesAlcoholic beveragesAlternative asset managersAluminumApparel and footwearAR VR mixed realityAsset managementAuto partsAutomotive OEMsAutonomous driving softwareBeauty and personal careBiofuelsBitcoin miningBlockchain platformsBrokerage and exchangesBuilding productsCannabisAll stocks
The other 156 themes
Carbon captureCarbon creditsCasual diningCell therapyCell tower REITCement and aggregatesCoal miningCobaltCommercial office REITCommodity chemicalsComputer visionConstruction and engineeringConsumer financeContainers and packagingContract research CDMOCopper miningCredit rating and dataCruise linesCryptocurrency and digital assetsCybersecurityData platformsDatacenter coolingDatacenter powerDatacenter REITDefense electronicsDefense prime contractorsDental careDeveloper toolsDiabetes careDiagnosticsDiamonds and gemstonesDiscount retailDrones and UAVEcommerce marketplacesEcommerce platformsEdge computingEdtechElectrical equipmentEnergy storageEsportsEV batteriesEV chargingEV makersFast food and quick serviceFintech softwareGambling and casinosGaming softwareGene therapyGenerative AIGeneric drugsGeothermalGLP 1 and obesityGold miningGPU cloud computeGraphiteGrocery and supermarketsHealth insuranceHealthcare REITHealthtech softwareHome improvementHomebuildersHospitals and providersHotel REITHotels and hospitalityHousehold productsHR techHVAC and controlsHydroelectricHydrogen economyIndustrial automationIndustrial gasesIndustrial machineryIndustrial REITInsurance brokersInvestment bankingIoT platformsIron oreLife insuranceLife science toolsLithium miningLogistics and 3PLLong term careLumber and forestryLuxury goodsMarine shippingMartech adtechMedical devicesMemory storage semisMissiles and munitionsMoney center banksMortgage financeMortgage REITmRNA platformsNatural gas utilitiesNeobanks and digital banksNeuroscienceNickelNon alcoholic beveragesNuclear powerOil and gas explorationOil and gas midstreamOil and gas refiningOil and gas servicesOnline travelPackaged foodsPayment processingPet carePharmaceuticals large capPotash fertilizerProperty casualty insurancePsychedelic therapeuticsQuantum computingRail transportRare diseaseRare earthsReal estate servicesRegional banksRegulated electric utilitiesReinsuranceRenewable energy developersResidential REITRetail REITRide hailing and deliveryRobotics hardwareSaaSSelf storage REITSemiconductor designSemiconductor equipmentSemiconductor manufacturingShipbuildingSilver miningSocial mediaSolarSpace launch and satellitesSpecialty chemicalsSpecialty financeSpecialty REITSpecialty retailSpeech and audio AISteelStreaming mediaSupply chain softwareSurgical roboticsTelecom equipmentTelecom infrastructureTelemedicineTobacco and nicotineTravel and leisureTrucking and LTLUranium miningVeterinary and animal healthVision and ophthalmologyWaste managementWater utilities and treatmentWealth managementWind